Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Unknown 4Completed 2

Sponsor Class

OTHER 99INDUSTRY 11UNKNOWN 6OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1Breast 1

Conditions

Stomach Neoplasms 2Esophageal Neoplasms 2Nasopharyngeal Carcinoma 1Breast Neoplasms 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Radiation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
UNKNOWN × nimotuzumab × Clear all
NCT01463605 2021-02-04

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

ChineseAMS

Phase 2 Completed
46 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03915132 2021-01-29

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Unknown
47 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

ChineseAMS

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01939054 2015-06-04

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

ChineseAMS

Phase 2 Unknown
90 enrolled
Breast

Breast Neoplasms

NCT02370849 2015-02-25

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

ChineseAMS

Phase 2 Completed
2 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01180166 2013-09-19

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

ChineseAMS

Phase 2 Unknown
30 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡